Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Without a specific news headline driving the move, DexCom (DXCM) sits at a recent close of US$70.69, leaving investors weighing its continuous glucose monitoring business against recent share price ...

Medtronic (NYSE:MDT) has completed the initial public offering of its MiniMed Group on the Nasdaq. The newly independent ...

Verizon is leveraging connectivity and devices to decentralize healthcare, enabling remote monitoring and telemedicine, ...

Rimidi's platform has demonstrated measurable impact on clinical outcomes, patient engagement and overall cost of care, including one healthcare partner achieving an average 2.8% reduction in ...